Laurion Capital Management’s Thermo Fisher Scientific TMO Stock Holding History

Laurion Capital Management’s Portfolio TMO Stock Details TMO Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2023 Q1	–	Sell	-68,200	Closed	-$37.6M	–	512
2022 Q4	$37.6M	Buy	68,200 +55,700	+446%	+$29.5M	0.18%	127
2022 Q3	$6.34M	Buy	12,500 +2,500	+25%	+$1.4M	0.04%	232
2022 Q2	$5.43M	Buy	+10,000	New	+$5.5M	0.08%	151
2020 Q1	–	Sell	-2,400	Closed	-$779K	–	1076
2019 Q4	$779K	Sell	2,400 -8,200	-77%	-$2.49M	0.01%	615
2019 Q3	$3.09M	Buy	10,600 +9,900	+1,414%	+$2.83M	0.02%	420
2019 Q2	$206K	Buy	+700	New	+$193K	﹤0.01%	824
2019 Q1	–	Sell	-45,200	Closed	-$10.1M	–	1284
2018 Q4	$10.1M	Buy	45,200 +40,000	+769%	+$9.38M	0.18%	149
2018 Q3	$1.27M	Buy	+5,200	New	+$1.2M	0.01%	628
2017 Q4	–	Sell	-2,200	Closed	-$416K	–	1842
2017 Q3	$416K	Buy	2,200 +800	+57%	+$145K	﹤0.01%	1225
2017 Q2	$244K	Buy	+1,400	New	+$235K	﹤0.01%	1493
2017 Q1	–	Sell	-10,500	Closed	-$1.48M	–	1560
2016 Q4	$1.48M	Buy	+10,500	New	+$1.55M	0.01%	645

Other funds holding TMO

BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return

Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM

State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return

Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return

Morgan Stanley New York $1.89T AUM 35.08% 1-Year Est. Return

JP Morgan Chase New York $1.81T AUM 41.13% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return

Franklin Resources San Mateo, California $462B AUM 39.16% 1-Year Est. Return

Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM

Capital World Investors Los Angeles, California $846B AUM 46.74% 1-Year Est. Return

Laurion Capital Management's TMO Position: Q2 2026 in Review

Laurion Capital Management sold out of Thermo Fisher Scientific (TMO) in Q2 2026, closing a stake of 3,980 shares — an estimated $1.96M sold.

Laurion Capital Management first reported a position in TMO in Q2 2015 and held it in 21 quarters. The position peaked at $61.5M in Q1 2024. 2,626 funds tracked by Wall St. Rank hold TMO as of Q2 2026.

Laurion Capital Management reported no remaining Thermo Fisher Scientific position as of Q2 2026 after selling out during the quarter.
Laurion Capital Management sold 3,980 Thermo Fisher Scientific shares in Q2 2026, an estimated $1.96M.
Laurion Capital Management first reported a position in Thermo Fisher Scientific in Q2 2015 and held it in 21 quarters.
Laurion Capital Management's Thermo Fisher Scientific position peaked at $61.5M in Q1 2024.
2,626 funds tracked by Wall St. Rank held Thermo Fisher Scientific as of Q2 2026.

Based on Laurion Capital Management's 13F filing for Q2 2026, filed 13 Aug 2026.